Evidence Hub

Modification of function in head-injured patients with Sinemet

Lal S, Merbtiz CP, Grip JC

Brain injury, 1988

12 participants

Abstract

The effects of Sinemet (levodopa + carbidopa) on 12 patients with head injury with diffuse brain damage were evaluated. All patients had suffered moderate to severe traumatic brain injury resulting in physical, cognitive, communicative, emotional and behavioural deficits. All patients had plateaued in their rehabilitation programmes for more than 2 weeks before initiation of Sinemet. All patients showed functional cognitive and behavioural improvement with Sinemet. The degree of improvement appears to depend on the pre-treatment condition and the time between injury and treatment. Larger controlled studies are recommended.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 12 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free